Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
7,121,492
-
Shares change
-
-58,841
-
Total reported value, excl. options
-
$157,598,296
-
Value change
-
-$855,471
-
Number of buys
-
25
-
Number of sells
-
22
-
Price
-
$22.13
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q3 2014
As of 30 Sep 2014 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,121,492 shares of stock of the company.
Largest 10 holders included Novo A/S, FMR LLC, HealthCor Management, L.P., RA CAPITAL MANAGEMENT, LLC, EAGLE ASSET MANAGEMENT INC, FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, MORGAN STANLEY, BlackRock Fund Advisors, and JENNISON ASSOCIATES LLC.
This table shows 62 institutional shareholders of the security as of 30 Sep 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.